B6J.B6N(Cg)-Isr(HSA17;MAPT*N279K)4Mdk/J

Stock number: 035794
Product name: MAPT(H1.0*)N279K-GR

Strain synonyms: B6J.B6N(Cg)-Tc(HSA17*N279K)1Mdk/J
Research areas: Mouse/Human Gene Homologs, Neurobiology Research

Description

MAPT(H1.0*N279K)-GR mice express the human MAPT (H1 haplotype) with the pathogenic N279K mutation, MAPT-AS1 transcripts and the typical MAPT protein isoforms.

Detailed description

The interspecies replacement (Isr) MAPT(H1.0*)N279K-GR (Gene Replacement) mice contain a syntenic 190 kb region from human chromosome 17 (HSA17) that includes SPPLC2 (signal peptide peptidase 2C) and MAPT (microtubule-associated protein tau), specifically, the H1 MAPT haplotype modified to express the N279K mutation. The region replaces 157 kb on mouse chromosome 11 stretching from, but not including, Crhr1 to Kansl1. The SPPL2C sequence is included because it is embedded entirely in the MAPT-AS1 transcribed region.

Human MAPT (microtubule-associated protein tau) is found within a 900 kb inversion on Chr 17q21 that defines two haplotypes, H1 and H2, found in Caucasians. The haplotypes are distinguished by a series of polymorphisms found in the MAPT sequence. A227A (GCA to GCG), is a silent point mutation in exon 9 of the MAPT isoform 441. The minor G allele is carried by the H2 haplotype, while the A allele is found in the more common H1 haplotype. H1 is linked with late onset Alzheimer's disease (AD) risk, progressive supranuclear palsy, Parkinson's disease, and corticobasal degeneration. MAPT(H1.0*)N279K-GR mice carry a N279K amino acid substitution associated with early onset frontotemporal dementia (FTD). H2 is associated with decreased risk of late onset AD, and lower MAPT levels in the cerebellum and temporal cortex. Homozygous mice are viable and fertile, no overt health or behavioral phenotype have been observed. These mice express the human MAPT (H1 haplotype) with the N279K risk variant, MAPT-AS1 transcripts and the typical MAPT protein isoforms.

Other strains from this set include: The H1 haplotype is distributed as Stock No. 035398 B6J.B6N-Isr(HSA17)2Mdk/J. A modified H1 haplotype carrying the pathogenic N279K mutation is distributed as Stock No. 035794. The H2 haplotype is distributed as Stock No. 033668 B6J.B6N(CBA)-Isr(HSA17)1Mdk/J. MAPT IVS10+16 C>T mice, distributed as Stock No. 036664, express the H1 haplotype and contain a non-coding C to T (rs63751011) mutation in intron 10. A modified H1 haplotype carrying the pathogenic L266V mutation is distributed as Stock No. 040834. A modified H1 haplotype carrying the pathogenic G272V mutation is distributed as Stock No. 040835.

Development

A 157 kb deletion on mouse chromosome 11 stretching from, but not including, Crhr1 to Kansl1 is replaced by a syntenic 190 kb region from human chromosome 17 (HSA17). In this interspecies replacement (Isr) strain, the mouse Sppl2c (signal peptide peptidase 2C) and Mapt (microtubule-associated protein tau) genes are replaced by human SPPL2C and MAPT (H1 haplotype) genes. The human MAPT gene was modified to include the N279K (asparaginine to lysine) mutation identified in FTD patients. The deletion/insertion was made using C57BL/6N-PRX-B6N embryonic stem cells (ES) and a loxN-flanked neomycin resistance cassette that was removed by transient cre expression prior to establishing the mouse line. Correctly targeted ES cells were injected into blastocysts. The resulting chimeric animals were crossed to C57BL/6J females. At some point MAPT(H1.0*)N279K-GR mice were crossed to mice carrying Tyr^c-2J, which was later bred out.  Upon arrival, mice were bred to C57BL/6J for at least 4 generations to establish the colony.

Allele

Symbol: Isr(HSA17;MAPT*N279K)4Mdk
Name: interspecies replacement, human Chr 17, Michael Koob 4
MGI accession ID: MGI:6705043
Generation method: Targeted
Attributes: Inserted expressed sequence; Humanized sequence
Synonyms: MAPT(H1.0*N279K)-GR; Tc(HSA17*N279K)1Mdk
Marker symbol: Isr(HSA17;MAPT*N279K)4Mdk
Marker name: interspecies replacement, human Chr 17, Michael Koob 4
Marker synonyms: Tc(HSA17*N279K)1Mdk
Chromosome: 11
Strain of origin: C57BL/6NTac
Molecular note: A 157 kb deletion on mouse chromosome 11 stretching from, but not including, Crhr1 to Kansl1 is replaced by a syntenic 190 kb region from human chromosome 17 (HSA17). The mouse Sppl2c (signal peptide peptidase 2C) and Mapt (microtubule-associated protein tau) genes are replaced by human SPPL2C and MAPT (H1 haplotype) genes. The human MAPT gene was modified to include the N279K (asparaginine to lysine) mutation identified in FTD patients. A loxN-flanked neomycin resistance cassette that was removed by transient cre expression.